Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines
暂无分享,去创建一个
[1] Ramesh Kumar,et al. Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease , 2022, World journal of hepatology.
[2] H. Yoshiji,et al. Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures , 2022, Advances in Therapy.
[3] A. de Gottardi,et al. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. , 2022, Journal of hepatology.
[4] J. Thachil,et al. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH , 2022, Journal of thrombosis and haemostasis : JTH.
[5] R. Tateishi,et al. Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease , 2021, Advances in Therapy.
[6] G. Su,et al. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis. , 2021, Gastroenterology.
[7] H. Maddur,et al. Avatrombopag Use in Patient With Thromboembolic Risks Listed for Combined Coronary Artery Bypass Grafting and Liver Transplant: A Case Report. , 2021, Transplantation proceedings.
[8] D. Valla,et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases , 2020, Hepatology.
[9] A. Shenoy,et al. Thromboelastography and Utility in Hepatology Practice , 2020, Clinical liver disease.
[10] S. Morjaria,et al. Rethinking the need for a platelet transfusion threshold of 50 × 109/L for lumbar puncture in cancer patients , 2020, Transfusion.
[11] S. Flamm,et al. Thrombocytopenia in Chronic Liver Disease: New Management Strategies. , 2020, Clinics in liver disease.
[12] W. Zhou,et al. Coronary artery bypass graft combined with liver transplantation in patients with advanced alcoholic liver cirrhosis: A case report , 2020, Experimental and therapeutic medicine.
[13] S. N. Sayar. Platelet , 2020, Definitions.
[14] Douglas A. Simonetto,et al. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. , 2020, The American journal of gastroenterology.
[15] J. S. Kim,et al. Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy , 2019, Gut and liver.
[16] S. Gamanagatti,et al. A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures , 2019, Digestive Diseases and Sciences.
[17] Hannah A. Blair,et al. Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure , 2019, Drugs.
[18] S. Caldwell,et al. Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists , 2019, Hepatology communications.
[19] S. Caldwell,et al. AGA Clinical Practice Update: Coagulation in Cirrhosis. , 2019, Gastroenterology.
[20] K. Simon,et al. Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2) , 2019, Hepatology.
[21] A. Saraya,et al. Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding , 2019, Digestive Diseases and Sciences.
[22] S. Agarwal,et al. Real-Time Ultrasound-Guided Paracentesis by Radiologists: Near Zero Risk of Hemorrhage without Correction of Coagulopathy. , 2019, Journal of vascular and interventional radiology : JVIR.
[23] P. Braz-Silva,et al. Bleeding during and after dental extractions in patients with liver cirrhosis. , 2018, International journal of oral and maxillofacial surgery.
[24] E. Giannini,et al. Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients. , 2018, Annals of hepatology.
[25] T. Hassanein,et al. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia. , 2018, Gastroenterology.
[26] H. Büller,et al. Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference , 2018, Thrombosis and Haemostasis.
[27] W. Middleton,et al. Bleeding Complications After Percutaneous Liver Biopsy: Do Subcapsular Lesions Pose a Higher Risk? , 2018, AJR. American journal of roentgenology.
[28] L. Cavanna,et al. Thoracentesis in advanced cancer patients with severe thrombocytopenia: Ultrasound guide improves safety and reduces bleeding risk , 2018, The clinical respiratory journal.
[29] M. Z. Ansari,et al. A Rare Etiology of Severe Thrombocytopenia in Patient with Chronic Liver Disease. , 2018, The Journal of the Association of Physicians of India.
[30] P. Rebulla,et al. Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] H. Tilg,et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III) , 2017, Wiener klinische Wochenschrift.
[32] H. J. Lee,et al. Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years. , 2017, Clinical radiology.
[33] M. Peck‐Radosavljevic. Thrombocytopenia in chronic liver disease , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[34] J. Hoofnagle,et al. Complications of percutaneous liver biopsy with Klatskin needles: a 36‐year single‐centre experience , 2017, Alimentary pharmacology & therapeutics.
[35] A. Andriulli,et al. Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. , 2017, European journal of internal medicine.
[36] Jonathan P. Kerr,et al. Guidelines for the use of platelet transfusions , 2017, British journal of haematology.
[37] J. Bosch,et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.
[38] S. Carossa,et al. Oral Surgical Treatment of Patients With Chronic Liver Disease: Assessments of Bleeding and Its Relationship With Thrombocytopenia and Blood Coagulation Parameters. , 2017, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[39] C. Zauner,et al. Coagulation parameters and major bleeding in critically ill patients with cirrhosis , 2016, Hepatology.
[40] A. Andriulli,et al. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[41] R. Montalti,et al. Thrombelastography‐guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial , 2016, Hepatology.
[42] John A. Evans,et al. The management of antithrombotic agents for patients undergoing GI endoscopy. , 2016, Gastrointestinal endoscopy.
[43] R. D. de Knegt,et al. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies , 2015, Drugs.
[44] P. Kamath,et al. Bleeding Rate for Ultrasound‐Guided Paracentesis in Thrombocytopenic Patients , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[45] A. Gialeraki,et al. Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility , 2015, Asian journal of transfusion science.
[46] Stephanie A. Smith,et al. How it all starts: Initiation of the clotting cascade , 2015, Critical reviews in biochemistry and molecular biology.
[47] S. Kleinman,et al. Platelet transfusion: a systematic review of the clinical evidence , 2015, Transfusion.
[48] Ashutosh Kumar Singh,et al. The safety of ultrasound guided central venous cannulation in patients with liver disease , 2015, Saudi journal of anaesthesia.
[49] Benjamin Djulbegovic,et al. Platelet Transfusion: A Clinical Practice Guideline From the AABB , 2015, Annals of Internal Medicine.
[50] M. Trivella,et al. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. , 2015, The Cochrane database of systematic reviews.
[51] Esther S. Kim,et al. Lusutrombopag: First Global Approval , 2015, Drugs.
[52] J. Barsuk,et al. Thoracentesis outcomes: a 12-year experience , 2014, Thorax.
[53] J. Puchalski. Thoracentesis and the risks for bleeding: a new era , 2014, Current opinion in pulmonary medicine.
[54] Amy Wang,et al. Routine laboratory testing before endoscopic procedures. , 2014, Gastrointestinal endoscopy.
[55] N. Dunbar,et al. Transfusion guidelines: when to transfuse. , 2013, Hematology. American Society of Hematology. Education Program.
[56] S. Caldwell,et al. Coagulation in liver disease: a guide for the clinician. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[57] T. Atwell,et al. Safety of ultrasound-guided thoracentesis in patients with abnormal preprocedural coagulation parameters. , 2013, Chest.
[58] P. Kamath,et al. Management of antithrombotic therapy in patients undergoing invasive procedures. , 2013, The New England journal of medicine.
[59] B. Runyon,et al. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012 , 2013, Hepatology.
[60] M. Poca,et al. Transfusion strategies for acute upper gastrointestinal bleeding. , 2013, The New England journal of medicine.
[61] R. Fanelli,et al. Adverse events of upper GI endoscopy. , 2012, Gastrointestinal endoscopy.
[62] A. Alves,et al. Postoperative bleeding after dental extraction in liver pretransplant patients. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[63] Donald L. Miller,et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. , 2009, Journal of vascular and interventional radiology : JVIR.
[64] O. Senn,et al. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia , 2011, Transfusion.
[65] Maitray D. Patel,et al. Abnormal preprocedural international normalized ratio and platelet counts are not associated with increased bleeding complications after ultrasound-guided thoracentesis. , 2011, AJR. American journal of roentgenology.
[66] Guang-shun Yang,et al. Risk Factors Influencing Postoperative Outcomes of Major Hepatic Resection of Hepatocellular Carcinoma for Patients with Underlying Liver Diseases , 2011, World Journal of Surgery.
[67] I. Sheen,et al. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. , 2011, World journal of gastroenterology.
[68] S. Maithel,et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. , 2011, Journal of the American College of Surgeons.
[69] William M. Lee,et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[70] E. Giannini,et al. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[71] F. Berthier,et al. Predictive factors of bleeding related to post‐banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case‐control study , 2010, Alimentary pharmacology & therapeutics.
[72] S. Basili,et al. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. , 2010, European journal of internal medicine.
[73] A. Tripodi. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No. , 2010, European journal of internal medicine.
[74] B. Spiess. Platelet transfusions: the science behind safety, risks and appropriate applications. , 2010, Best practice & research. Clinical anaesthesiology.
[75] Jeffrey McCullough,et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. , 2010, The New England journal of medicine.
[76] S. Trerotola,et al. Large-bore tunneled central venous catheter insertion in patients with coagulopathy. , 2010, Journal of vascular and interventional radiology : JVIR.
[77] K. R. Prasad,et al. Predictors of blood transfusion requirement in elective liver resection. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[78] J. Mössner,et al. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis , 2010, BMC gastroenterology.
[79] S. Curley,et al. Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. , 2010, Surgery.
[80] S. Ammar. Management of complicated umbilical hernias in cirrhotic patients using permanent mesh: randomized clinical trial , 2010, Hernia.
[81] J. Madariaga,et al. Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child–Pugh classification in predicting outcome , 2010, Surgical Endoscopy.
[82] A. Muneer,et al. Laparoscopic Cholecystectomy in Cirrhotic Patients , 2009, JSLS : Journal of the Society of Laparoendoscopic Surgeons.
[83] G. Chau,et al. Predicting Morbidity and Mortality After Hepatic Resection in Patients with Hepatocellular Carcinoma: The Role of Model for End-Stage Liver Disease Score , 2009, World Journal of Surgery.
[84] F. Carrilho,et al. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[85] A. de Gottardi,et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[86] R. Makuch,et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[87] R. Nelson,et al. Liver biopsy , 2009, Hepatology.
[88] J. Eikenboom,et al. The clinical impact of platelet refractoriness: correlation with bleeding and survival , 2008, Transfusion.
[89] M. Manns,et al. Thrombocytopenia associated with chronic liver disease. , 2008, Journal of hepatology.
[90] L. Oğuzkurt,et al. US-guided placement of central vein catheters in patients with disorders of hemostasis. , 2008, European journal of radiology.
[91] Matthew S. Johnson,et al. Time to hemostasis after traction removal of tunneled cuffed central venous catheters. , 2007, Journal of vascular and interventional radiology : JVIR.
[92] A. Loh,et al. Port-A-Cath insertions in acute leukemia: does thrombocytopenia affect morbidity? , 2007, Journal of pediatric surgery.
[93] S. Kubo,et al. Risk factors for massive blood loss during liver resection for hepatocellular carcinoma in patients with cirrhosis. , 2007, Hepato-gastroenterology.
[94] M. Toungouz,et al. GUIDELINES FOR THE TRANSFUSION OF PLATELETS , 2007, Acta clinica Belgica.
[95] P. Mannucci,et al. Thrombin generation in patients with cirrhosis: The role of platelets , 2006, Hepatology.
[96] E. D. da Silveira. Outcome of cirrhotic patients undergoing cholecystectomy: Applying Bayesian analysis in gastroenterology , 2006, Journal of gastroenterology and hepatology.
[97] M. Ma,et al. Should bleeding tendency deter abdominal paracentesis? , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[98] E. DeMaria,et al. Poor outcomes in cirrhosis-associated hernia repair: a nationwide cohort study of 32,033 patients , 2005, Hernia.
[99] J. Prieto,et al. The Role of Thrombopoietin in the Thrombocytopenia of Patients with Liver Cirrhosis , 2005, The American Journal of Gastroenterology.
[100] M. Bilodeau,et al. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease , 2005, Alimentary pharmacology & therapeutics.
[101] William M. Lee,et al. Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. , 2004, Controlled clinical trials.
[102] P. Kamath,et al. Performance standards for therapeutic abdominal paracentesis , 2004, Hepatology.
[103] S. Body,et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes , 2004, Transfusion.
[104] B. Runyon. Management of adult patients with ascites due to cirrhosis , 2004, Hepatology.
[105] R. Groszmann,et al. American association for the study of liver diseases , 1992 .
[106] Guidelines for the use of platelet transfusions , 2003, British journal of haematology.
[107] K. Ahrar,et al. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. , 2003, Journal of vascular and interventional radiology : JVIR.
[108] J. Wong,et al. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma , 2003, The British journal of surgery.
[109] H. Sørensen,et al. Thirty‐day case fatality after nephrectomy in patients with liver cirrhosisA Danish population‐based cohort study , 2003, Scandinavian journal of urology and nephrology.
[110] C. Begley,et al. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. , 2002, Blood.
[111] G. Demetri,et al. Targeted approaches for the treatment of thrombocytopenia. , 2001, The oncologist.
[112] H. Vilstrup,et al. Postoperative mortality in patients with liver cirrhosis undergoing transurethral resection of the prostate: a Danish nationwide cohort study , 2001, BJU international.
[113] J. James,et al. A Novel Approach to the Assessment of Variations in the Human Platelet Count , 2000, Thrombosis and Haemostasis.
[114] P. Thampanitchawong,et al. Liver biopsy:complications and risk factors. , 1999, World journal of gastroenterology.
[115] J. Vozenilek,et al. Laparoscopic cholecystectomy in cirrhotic patients. , 1998, Journal of the American College of Surgeons.
[116] A. Gangl,et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? , 1997, Journal of hepatology.
[117] C. Ray,et al. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. , 1997, Radiology.
[118] T. Pilgram,et al. Evaluation of coagulation tests as predictors of angiographic bleeding complications. , 1996, Radiology.
[119] P. Clavien,et al. Definition and Classification of Negative Outcomes in Solid Organ Transplantation Application in Liver Transplantation , 1994, Annals of surgery.
[120] E. Christensen,et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study , 1994 .
[121] E. Christensen,et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). , 1994, Journal of hepatology.
[122] M. Hart,et al. Central venous catheterization in patients with coagulopathy. , 1992, Archives of surgery.
[123] P. Toy,et al. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. , 1990, American journal of clinical pathology.
[124] M. Banaji,et al. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. , 1982, Journal of clinical gastroenterology.
[125] K. Ewe,et al. [The bleeding time after liver biopsy does not correlate with peripheral coagulation factors]. , 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin.
[126] D. Zimmon,et al. The portal pressure-blood volume relationship in cirrhosis 1 , 1974, Gut.
[127] J. Boyer,et al. Effect of plasma-volume expansion on portal hypertension. , 1966, The New England journal of medicine.
[128] R. Aster. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. , 1966, The Journal of clinical investigation.